Enhanced Quality of Life : Patients reported feeling more energetic and confident, leading to an overall boost in well-being
Tirzepatide (Zepbound) Clinical trial data cited by multiple sources, including NBC News, showed average weight loss of approximately 21 to 22.5 percent at the highest dose after 72 weeks, compared with about 3 percent for placebo
Our clinical approach includes: Full health and hormone consultation Blood tests to measure GH, IGF-1, testosterone, thyroid, and metabolic markers Tailored prescription of approved peptide compounds selected for tissue repair, cellular energy support, or muscle recover, based on your individual assessment Integration with nutrition, exercise, and recovery plans Regular follow-ups to adjust dosing and monitor outcomes Peptide therapy is designed to work synergistically with TRT, GH, or lifestyle optimisation, supporting both health and physical performance
AE leading to drug discontinuation were observed in 16% of participants with the 12 mg dose, but the overall incidence of SAE was low (up to 6-8%)
The quality of the vials appeared to be substandard while the labels were dodgy